Da­ta an­a­lyt­ics looms large as Pharm­Stars dig­i­tal health ac­cel­er­a­tor wraps first 'Phar­mU' start­up class

Class is dis­missed for Pharm­Stars’ first co­hort of dig­i­tal health start­up com­pa­nies. The phar­ma-fo­cused ac­cel­er­a­tor re­cent­ly grad­u­at­ed 12 com­pa­nies af­ter a 10-week ed­u­ca­tion­al pro­gram and a fi­nal show­case meet-up with six phar­ma mem­bers – Boehringer In­gel­heim, Eli Lil­ly, No­vo Nordisk, Sum­i­to­vant Bio­phar­ma, Take­da and Alex­ion (now part of As­traZeneca).

The fi­nal 12 – bumped up from an ini­tial ex­pect­ed class size of 10 af­ter 73 ap­pli­ca­tions poured in – are now in var­i­ous stages of talks with the phar­ma com­pa­nies about next steps. While it’s too ear­ly to re­port any fi­nal deals or part­ner­ships, Pharm­Stars’ founder and CEO Nao­mi Fried ap­plaud­ed first-round ef­forts and ex­pects there will be news in the up­com­ing weeks.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER